Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.

Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K, Reed S, Rexrode K, Shifren J, Sternfeld B, Ensrud K.

Menopause. 2014 Nov 17. [Epub ahead of print]

PMID:
25405571
2.

Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature.

Suri R, Lin AS, Cohen LS, Altshuler LL.

J Clin Psychiatry. 2014 Oct;75(10):e1142-52. doi: 10.4088/JCP.13r08926. Review.

PMID:
25373125
3.

Prevalence of atypical antipsychotic use in psychiatric outpatients: comparison of women of childbearing age with men.

Camsarı U, Viguera AC, Ralston L, Baldessarini RJ, Cohen LS.

Arch Womens Ment Health. 2014 Dec;17(6):583-6. doi: 10.1007/s00737-014-0465-0. Epub 2014 Sep 25.

PMID:
25253022
4.

Comparing college smokers' and dual users' expectancies towards cigarette smoking.

Gottlieb JC, Cohen LM, Haslam AK.

Addict Behav. 2014 Dec;39(12):1784-8. doi: 10.1016/j.addbeh.2014.07.015. Epub 2014 Jul 17.

PMID:
25123347
5.

Omega-3 Fatty acids and gestational length in a high-risk psychiatric population due to psychiatric morbidity and medication exposure during pregnancy.

Freeman MP, Cohen LS, McInerney K.

J Clin Psychopharmacol. 2014 Oct;34(5):627-32. doi: 10.1097/JCP.0000000000000168.

PMID:
25006815
6.

Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.

Reed SD, Mitchell CM, Joffe H, Cohen L, Shifren JL, Newton KM, Freeman EW, Larson JC, Manson JE, LaCroix AZ, Guthrie KA.

Obstet Gynecol. 2014 Aug;124(2 Pt 1):233-41. doi: 10.1097/AOG.0000000000000386.

PMID:
25004335
7.

Antidepressant use in pregnancy and the risk of cardiac defects.

Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S.

N Engl J Med. 2014 Jun 19;370(25):2397-407. doi: 10.1056/NEJMoa1312828.

8.

Arf1 and Arf6 promote ventral actin structures formed by acute activation of protein kinase C and Src.

Caviston JP, Cohen LA, Donaldson JG.

Cytoskeleton (Hoboken). 2014 Jun;71(6):380-94. doi: 10.1002/cm.21181. Epub 2014 Jun 26.

PMID:
24916416
9.

Discontinuation of antidepressants during attempts to conceive: a pilot trial of cognitive behavioral therapy for the prevention of recurrent depression.

Psaros C, Freeman M, Safren SA, Barsky M, Cohen LS.

J Clin Psychopharmacol. 2014 Aug;34(4):455-60. doi: 10.1097/JCP.0000000000000158.

PMID:
24911438
10.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.

Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L.

JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891.

11.

Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.

Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-LaForce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE, Freeman EW, Hunt JR, Joffe H, Larson JC, Learman LA, Rothenberg R, Seguin RA, Sherman KJ, Sternfeld BS, LaCroix AZ.

Am J Obstet Gynecol. 2014 Mar;210(3):244.e1-11. doi: 10.1016/j.ajog.2013.11.016. Epub 2013 Nov 8.

12.

Assisted reproduction and risk of depressive relapse: considerations for treatment.

Freeman MP, Toth TL, Cohen LS.

Ann Clin Psychiatry. 2013 Nov;25(4):283-8. Review.

PMID:
24199219
13.

Efficacy of yoga for vasomotor symptoms: a randomized controlled trial.

Newton KM, Reed SD, Guthrie KA, Sherman KJ, Booth-LaForce C, Caan B, Sternfeld B, Carpenter JS, Learman LA, Freeman EW, Cohen LS, Joffe H, Anderson GL, Larson JC, Hunt JR, Ensrud KE, LaCroix AZ.

Menopause. 2014 Apr;21(4):339-46. doi: 10.1097/GME.0b013e31829e4baa.

PMID:
24045673
14.

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial.

Cohen LS, Joffe H, Guthrie KA, Ensrud KE, Freeman M, Carpenter JS, Learman LA, Newton KM, Reed SD, Manson JE, Sternfeld B, Caan B, Freeman EW, LaCroix AZ, Tinker LF, Booth-Laforce C, Larson JC, Anderson GL.

Menopause. 2014 Apr;21(4):347-54. doi: 10.1097/GME.0b013e31829e40b8.

PMID:
23982113
15.

Efficacy of exercise for menopausal symptoms: a randomized controlled trial.

Sternfeld B, Guthrie KA, Ensrud KE, LaCroix AZ, Larson JC, Dunn AL, Anderson GL, Seguin RA, Carpenter JS, Newton KM, Reed SD, Freeman EW, Cohen LS, Joffe H, Roberts M, Caan BJ.

Menopause. 2014 Apr;21(4):330-8. doi: 10.1097/GME.0b013e31829e4089.

PMID:
23899828
16.

Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.

Newton KM, Carpenter JS, Guthrie KA, Anderson GL, Caan B, Cohen LS, Ensrud KE, Freeman EW, Joffe H, Sternfeld B, Reed SD, Sherman S, Sammel MD, Kroenke K, Larson JC, Lacroix AZ.

Menopause. 2014 Jan;21(1):45-58. doi: 10.1097/GME.0b013e31829337a4.

17.

Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.

Freeman MP, Hirschberg AM, Wang B, Petrillo LF, Connors S, Regan S, Joffe H, Cohen LS.

Maturitas. 2013 Jun;75(2):170-4. doi: 10.1016/j.maturitas.2013.03.007. Epub 2013 Apr 17.

PMID:
23602542
18.

Disparate rates of new-onset depression during the menopausal transition in 2 community-based populations: real, or really wrong?

Harlow BL, MacLehose RF, Smolenski DJ, Soares CN, Otto MW, Joffe H, Cohen LS.

Am J Epidemiol. 2013 May 15;177(10):1148-56. doi: 10.1093/aje/kws365. Epub 2013 Apr 14.

19.

The development and psychometric evaluation of the Smokeless Tobacco Expectancies Scale (STES).

Gottlieb JC, Cohen LM, Demarree KG, Treloar HR, McCarthy DM.

Psychol Assess. 2013 Sep;25(3):997-1001. doi: 10.1037/a0032256. Epub 2013 Apr 1.

20.

Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experience.

Sternfeld B, LaCroix A, Caan BJ, Dunn AL, Newton KM, Reed SD, Guthrie KA, Booth-LaForce C, Sherman KJ, Cohen L, Freeman MP, Carpenter JS, Hunt JR, Roberts M, Ensrud KE.

Contemp Clin Trials. 2013 May;35(1):25-34. doi: 10.1016/j.cct.2013.02.009. Epub 2013 Feb 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk